| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,333 |
8,190 |
$1.40M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,015 |
6,466 |
$994K |
| A0425 |
Ground mileage, per statute mile |
2,222 |
1,752 |
$335K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
778 |
678 |
$262K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,708 |
1,496 |
$124K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,670 |
1,517 |
$41K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,542 |
1,408 |
$36K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
127 |
110 |
$35K |
| S5170 |
Home delivered meals, including preparation; per meal |
5,607 |
269 |
$32K |
| 87631 |
|
161 |
151 |
$24K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
735 |
681 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
626 |
366 |
$21K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
178 |
160 |
$21K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
191 |
176 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
2,722 |
2,245 |
$14K |
| 0001A |
|
392 |
384 |
$10K |
| 87634 |
|
191 |
176 |
$10K |
| 0002A |
|
368 |
361 |
$10K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
45 |
14 |
$7K |
| 80053 |
Comprehensive metabolic panel |
115 |
105 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
131 |
60 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
25 |
24 |
$3K |
| 86140 |
|
181 |
170 |
$3K |
| 80076 |
|
186 |
177 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
30 |
25 |
$2K |
| 94761 |
|
58 |
55 |
$2K |
| 83605 |
|
56 |
51 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
32 |
29 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
32 |
29 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12 |
12 |
$1K |
| 71045 |
Radiologic examination, chest; single view |
14 |
13 |
$992.67 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
36 |
35 |
$889.70 |
| 84443 |
Thyroid stimulating hormone (TSH) |
40 |
37 |
$880.12 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
28 |
27 |
$662.14 |
| A9270 |
Non-covered item or service |
901 |
629 |
$616.32 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
43 |
38 |
$585.49 |
| 0011A |
|
16 |
16 |
$531.54 |
| 0012A |
|
17 |
17 |
$531.54 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
14 |
12 |
$478.84 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16 |
15 |
$263.86 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
39 |
24 |
$226.67 |
| 80061 |
Lipid panel |
15 |
12 |
$168.34 |
| 86592 |
|
12 |
12 |
$154.22 |
| 82565 |
|
19 |
19 |
$51.19 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
12 |
$38.05 |
| 81001 |
|
14 |
12 |
$28.45 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
17 |
16 |
$0.00 |